Corporate Accountability
Justices’ Questions Bode Well for ACA’s Future
At any argument, there are always tough questions for both sides, but the government has to have been happy about the questions that were asked during the King argument — as well as the answers that Verrilli was able to give.
More from Corporate Accountability
U.S. Court of Appeals for the Third Circuit
Novartis v. Secretary United States Department of Health and Human Services
In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit is considering whether the Inflation Reduction Act’s Medicare drug price negotiation program is...
January 28, 2025
Federal Deposit Insurance as Jarkesy Waiver
An argument lurking just beneath the surface in a pending Fifth Circuit case could stem...
U.S. Court of Appeals for the Second Circuit
Boehringer Ingelheim v. Department of Health and Human Services
In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit is considering whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
U.S. Court of Appeals for the Fifth Circuit
Ortega v. Office of the Comptroller of the Currency
In Ortega v. Office of the Comptroller of the Currency, the United States Court of Appeals for the Fifth Circuit is considering a challenge to the Office of the Comptroller of the Currency’s authority to...
U.S. Court of Appeals for the Fifth Circuit
Burgess v. Whang
In Burgess v. Whang, the Fifth Circuit is considering a challenge to the Federal Deposit Insurance Corporation’s authority to issue penalties and other supervisory orders.
October 23, 2024
The Constitution Doesn’t Entitle Drug Manufacturers to a Sweetheart Deal
Big Pharma is in federal appeals court making the absurd argument that Medicare shouldn’t be...